Navigation Links
Zogenix Secures $35 Million Debt Facility and Raises $15 Million Investment Capital
Date:7/13/2010

science and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $1.5 billion in loans, with lines of credit ranging from $500 thousand to $40 million. Oxford is headquartered in Alexandria, Virginia, with additional offices in California and Massachusetts. For more information visit www.oxfordfinance.com.

About Silicon Valley Bank

Silicon Valley Bank (SVB) is the premier commercial bank for companies in the technology, life science, venture capital, private equity and premium wine industries. SVB provides a comprehensive suite of financing solutions, treasury management, corporate investment and international banking services to its clients worldwide. Through its focus on specialized markets and extensive knowledge of the people and business issues driving them, Silicon Valley Bank provides a level of service and partnership that measurably impacts its clients' success. Founded in 1983 and headquartered in Santa Clara, Calif., the company serves clients around the world through 26 US offices and international operations in China, India, Israel and the United Kingdom. Silicon Valley Bank is a member of global financial services firm SVB Financial Group (Nasdaq: '/>"/>

SOURCE Zogenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Zogenix Initiates Pivotal Phase 3 Clinical Trial for Novel Formulation of Oral Controlled-Release Hydrocodone
2. DURECT Corporation Secures $50 Million Committed Equity Financing Facility
3. ProUroCare Medical Secures $885,000 in Financing
4. Bacterin International Secures Three-Year Agreement to Distribute Biologic Products to Broadlanes Network of Over 6,000 Medical Facilities
5. Alexza Secures $25 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd.
6. Logical Therapeutics Secures $16.9M Series C Financing Round
7. Breathe Technologies Secures $23 Million in Series C Financing
8. Johnson Controls Secures Global Facilities Management Win With GlaxoSmithKline
9. NxStage(R) Secures $15 Million Revolving Line of Credit
10. TransMedics, Inc. Secures $36 Million Round of Financing Lead by Foundation Capital and Kleiner Perkins Caufield & Byers
11. Poniard Pharmaceuticals Secures $20 Million Committed Equity Financing Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Pharmaceuticals, Inc. (Nasdaq: ISIS ) today reported pro ... months ended March 31, 2015 compared to a pro ... same period in 2014.  Isis, significantly improved financial results ... from its partners compared to the same quarter last ... from operations of $9.3 million for the three months ...
(Date:5/5/2015)...  Accuray Incorporated (Nasdaq: ARAY ), announced today that ... America Merrill Lynch 2015 Healthcare Conference in ... at 2:20pm PT.   A live webcast ... Relations page of the Company,s website at http://www.accuray.com/investors ... approximately one hour after the conclusion of the live ...
(Date:5/5/2015)... May 5, 2015  Kewaunee Scientific Corporation (NASDAQ: KEQU ... to Kewaunee Scientific,s Board of Directors, effective April 29, ... North Carolina . The election of Mr. ... notification to the Board of his intention to resign from ... professional commitments. Upon his election, Mr. Gehl was also elected ...
Breaking Medicine Technology:Isis Reports Financial Results and Highlights for First Quarter 2015 2Isis Reports Financial Results and Highlights for First Quarter 2015 3Isis Reports Financial Results and Highlights for First Quarter 2015 4Isis Reports Financial Results and Highlights for First Quarter 2015 5Isis Reports Financial Results and Highlights for First Quarter 2015 6Isis Reports Financial Results and Highlights for First Quarter 2015 7Isis Reports Financial Results and Highlights for First Quarter 2015 8Isis Reports Financial Results and Highlights for First Quarter 2015 9Isis Reports Financial Results and Highlights for First Quarter 2015 10Isis Reports Financial Results and Highlights for First Quarter 2015 11Isis Reports Financial Results and Highlights for First Quarter 2015 12Isis Reports Financial Results and Highlights for First Quarter 2015 13Keith M. Gehl Elected to Kewaunee Scientific Board of Directors 2Keith M. Gehl Elected to Kewaunee Scientific Board of Directors 3
... for Clinical Trial of ALXN6000 in Cancer, ... ALXN ) today announced that the U.S. ... titled,"Polypeptides and Antibodies Derived from Chronic Lymphocytic Leukemia,Cells ... Alexion and includes,claims that encompass the composition-of-matter of ...
... Broad New Patent Granted, CAMBRIDGE, Mass. and CARLSBAD, ... and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ),today announced ... mipomersen in,patients with heterozygous familial hypercholesterolemia (heFH), a genetic,disorder ... is,the first of four new trials the companies plan ...
Cached Medicine Technology:Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody 2Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody 3Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody 4Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen 2Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen 3Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen 4Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen 5Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen 6Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen 7
(Date:5/5/2015)... On May, 5, 2015, My Positive Perspective host ... about alternatives for youngsters to do this summer. As the ... idea for starting a summer camp and how is it ... called Once Upon a Party and I come to children’s ... even scripture. We play games, sing, and dance and have ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 For the growing ... HiTemp140 series of data loggers. This data logger ... the electronic components for optimum performance throughout exposure to high ... data loggers are capable of storing up to 32,700 ... battery life of one year or longer. All data loggers ...
(Date:5/5/2015)... May 05, 2015 In the upbeat Moms ... is for moms to support each other. Parenting is ... other’s side makes it so much easier. Mothers talk ... better, feel less alone and help them realize there’s no ... Moms who are clearly dear friends share that it's ...
(Date:5/5/2015)... Buckeye Health Plan (BHP) is pleased to ... president of Buckeye Health Plan. Hill, known for growing ... Hill has more than 28 years of healthcare leadership ... managed care to large health care provider systems. Most ... of Michigan, a health plan serving the Medicaid, Medicare ...
(Date:5/5/2015)... KNOXVILLE, Tenn. (PRWEB) May 05, 2015 ... company that provides innovative interoperability solutions for hospitals ... ROI cost savings calculator. Hospital CIOs and CTOs ... at healthslide.com. The calculator shows both initial and ... offering, Boomerang. , “Our nation’s hospitals pay ...
Breaking Medicine News(10 mins):Health News:My Positive Perspective Hosts Episode Informing People of a True Princess Summer Camp With Irene Rose 2Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 2Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 3Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 4Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 5Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 6Health News:Just In Time For Mother’s Day, Healthy Birth Day Releases Video Titled “Moms Helping Moms” Encouraging Mothers To Band Together 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 2Health News:Buckeye Health Plan Announces New Chief Executive Officer 3Health News:HealthSlide Launches ROI Cost Calculator 2
... 26 Pregis Corporation, a leading international manufacturer, marketer, ... solutions, today announced its 2008 fourth quarter and full ... Company generated net sales of $219.6 million, a decrease ... the fourth quarter of 2007. Excluding incremental revenue ...
... March 26 Abusing real-time communication tools like instant ... of sales reps to engage with physicians."A lot of ... more efficient," stated a sales executive in a roundtable ... "In reality, they,re so distracted by doing four things ...
... suppresses enzyme vital to tumor growth , , THURSDAY, March 26 ... also help slow the spread of a deadly type of ... published in the current issue of the International Journal ... telomerase. Telomerase activity appears to be essential for certain tumor ...
... PLEASANTON, Calif., FRAMINGHAM, Mass. and SYDNEY, Australia, ... ), a leader in device-based mechanical circulatory support therapies ... International, Inc. (Nasdaq: HTWR ; ASX: HIN), ... today that they each received a Request for Additional ...
... Patient Health and Safety and Pharmaceutical Innovation ... Generic Pharmaceutical Association (GPhA) released the following ... Kathleen Jaeger regarding the bipartisan Senate introduction ... Life-Saving Medicine Act.""Momentum is skyrocketing for biogenerics ...
... Safeguard and Comerica Debt Facilities; Support Robust GrowthALISO VIEJO, ... CLRT ), a premier anatomic pathology and ... pharmaceutical industry, announced today that it has entered into ... Oak Investment Partners , a multi-stage venture capital ...
Cached Medicine News:Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 2Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 3Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 4Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 5Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 6Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 7Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 8Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 9Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 10Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 11Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 12Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 13Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 14Health News:Pregis Announces Fourth Quarter and Full Year 2008 Financial Results 15Health News:Sales Force Effectiveness: Less Texting, More Engagement 2Health News:Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission 2Health News:Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission 3Health News:Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission 4Health News:Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission 5Health News:GPhA Statement on the Introduction of the Bipartisan Senate Biogenerics Consensus Bill: 'Promoting Innovation and Access to Life-Saving Medicine Act' 2Health News:Clarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment Partners 2Health News:Clarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment Partners 3Health News:Clarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment Partners 4Health News:Clarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment Partners 5Health News:Clarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment Partners 6Health News:Clarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment Partners 7Health News:Clarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment Partners 8
Topics include: ECG reading, ACLS (all the latest protocols and pearls), CHF, acute MI, cardiac testing, palpitations, pericarditis, arrhythmias, murmurs, athletes, valvular disease, endocarditis, sy...
Cardiology Intensive Board Review is geared specifically to candidates taking the Cardiovascular Boards and the Cardiovascular section of the Internal Medicine Boards....
... provides leading edge information ... involving all aspects of ... on diagnosis and management ... venous disease. CVMstat® reviews ...
A Practical Approach to TEE puts detailed "how-to" information on transesophageal echocardiography (TEE) at the clinician's fingertips in the operating room, intensive care unit, office, or any other...
Medicine Products: